Project Grant R01GM152664
- Federal Project Grant Award Summary The Wistar Institute of Anatomy and Biology received a $363,191 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through January 31, 2031. This award supports fundamental biomedical research investigating the role of non-canonical nucleic acid structures—specifically R-loops (three-stranded RNA-DNA hybrid structures) and...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $506,550 to The Wistar Institute of Anatomy and Biology under the Biomedical Research and Research Training program (CFDA 93.859) on April 1, 2026, for a five-year project period concluding March 31, 2031. This Project Grant funds fundamental biomedical research investigating the mechanisms controlling the development of TIM4+ macrophages, specialized immune cells responsible for efficiently...
- Federal Grant Award Summary The University of Pennsylvania received a $147,486 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 1, 2025, with completion targeted for January 31, 2028. The grant funds research to investigate the molecular mechanisms governing the spatial and temporal coordination of DNA replication and transcription during embryonic development. The project...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Stanford University a $157,388 Project Grant on August 9, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support fundamental research on nucleosome engagement through chemically induced proximity (CIP) methodology. The research initiative, scheduled for completion by August 8, 2027, aims to develop novel approaches for rewiring protein-nucleosome interactions by...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Regents of the University of Colorado a Project Grant of $307,854 under the Biomedical Research and Research Training program (CFDA 93.859) to conduct fundamental research on RNA Polymerase II (Pol II) transcriptional termination mechanisms. The award, effective April 3, 2026, with completion targeted for December 31, 2029, supports investigator-initiated basic research at the University of...
- Federal Project Grant Award Summary The Stowers Institute for Medical Research received a $429,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective February 13, 2026, through January 31, 2031. This five-year award supports fundamental research investigating the function of maternal messenger RNA (mRNA) during zebrafish embryogenesis, specifically examining the molecular mechanisms...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Pennsylvania a Project Grant totaling $446,875 on August 8, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to support research through June 30, 2030. This award funds fundamental basic research investigating novel cell death mechanisms and metabolic reprogramming in response to microenvironmental stress. The research combines cell and genome...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Pennsylvania a Project Grant totaling $406,250 under the Biomedical Research and Research Training program (CFDA 93.859) on March 2, 2026, with completion targeted for December 31, 2030. This five-year research initiative advances nucleic acid chemistry and in vitro selection (SELEX) techniques to expand the genetic toolkit for RNA silencing and editing applications. The...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Research Foundation For The State University Of New York a Project Grant totaling $299,673 under the Biomedical Research and Research Training program (CFDA 93.859) for research investigating regulatory mechanisms of in vivo transcriptional dynamics. The award, effective April 1, 2026, through December 31, 2030, supports fundamental research aimed at elucidating how transcriptional bursting—the...
- Federal Project Grant Award Summary Indiana University Indianapolis received a $332,403 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026, through May 31, 2030. This focused technology research and development award supports the identification and characterization of the interactome and function of spinophilin and neurabin—two abundant protein phosphatase 1 (PP1)...
The Wistar Institute of Anatomy and Biology received a $591,549 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026 through March 31, 2031. The award funds fundamental molecular biology research investigating the control of transcriptional integrity through the Integrator complex and PP2A phosphatase. The research focuses on understanding RNA Polymerase II (RNAPII) pausing mechanisms and pause-release regulation, with particular emphasis on how disease-associated mutations in PP2A phosphatase alter transcriptional elongation patterns. The research deliverables include three primary investigations: determining how the INT-PP2A module establishes paused RNAPII through the INTS3 subunit; evaluating the role of PP2A carboxy-methylation in transcriptional regulation; and assessing the effects of mutant PP2A on transcription in neuronal differentiation models. This basic research initiative aims to advance understanding of fundamental biological processes underlying gene expression regulation, with potential applications to disease diagnosis and treatment development across multiple therapeutic areas.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $591.5k | 5/25/26 |